Jiangsu Hengrui Medicine Co., Ltd.

Hengrui Medicine is a leading pharmaceutical company based in China focused on research, development, manufacturing and commercialization of innovative and high-quality healthcare products. Restructured into a joint-stock company in 1997 and listed on the Shanghai Stock Exchange in 2000 under stock code 600276, the company ranks among the top 30 worldwide in the pharmaceutical industry by market capitalization, exceeding 55 billion USD, with more than 21,900 employees worldwide and a leading position in cancer drugs and contrast agents.